UNSPSC 85892410: Low dose rate (ldr) brachytherapy of eye using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of eye using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D810B9Z

UNSPSC 85892410 Low dose rate (LDR) brachytherapy of eye using iodine 125 (I-125) is a Commodity code whose nominal scope—specialized cancer treatment for ocular tumors—shows no alignment with recent state and local procurement activity. The single recent opportunity in the dataset, posted by the County of Santa Clara Health System in July 2026, solicits temporary health professional staffing services across thirteen ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic, respiratory care, sterile processing, surgical and operating room, and therapy services. The code's appearance in this procurement is a classification mismatch; the Health System's RFQ targets staffing placement services, not brachytherapy equipment, supplies, or procedural contracting.

The County of Santa Clara Health System RFQ (RFSQHHSFY270052), due October 7, 2026, establishes a non-exclusive, multiple-award qualified vendor pool with no guaranteed work volume and permits placement on the list for five years as operational needs arise. Proposers may bid for all or specific health professional categories without penalty for single-specialty focus. The code shows no other documented state or local contract activity and does not reflect a viable procurement category for brachytherapy vendors or related medical device and radiation oncology suppliers. Firms pursuing state and local procurement in specialized cancer treatment modalities should monitor alternate UNSPSC categories aligned with medical device procurement, radiation therapy equipment, or outpatient oncology service contracts rather than this classification.